课题基金 / 基金详情

Molecular Calssification of Basal Cell Carcinomas

Molecular Calssification of Basal Cell Carcinomas
基底细胞癌的分子分类
批准号:
6795058
负责人:
Allen Everett Bale
金额:
$16.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-26 至 2006-07-31

项目摘要

项目成果

Allen Everett Bale的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Basal cell carcinoma of the skin is by far the most common type of cancer in the United States, representing nearly one half of all newly diagnosed malignancies. Although these tumors infrequently cause cancer mortality, they are associated with significant morbidity due to local invasion and tissue destruction. Basal cell carcinomas are extremely variable in gross and microscopic appearance and biological behavior, and a common histopathologic classification system divides the tumors into five main categories which differ in aggressiveness, prognosis, and response to therapy. My laboratory isolated a gene for hereditary basal cell carcinomas (human patched; gene symbol PTCH) and showed that this gene is mutated in sporadic BCCs as well. Exactly analogous to the two-hit paradigm established for retinoblastoma, almost all sporadic basal cell tumors have two somatically-derived, inactivating PTCH mutations. PTCH is a member of the hedgehog signal transduction pathway. The few BCCs lacking mutations in PTCH have activating mutations in smoothened (SMO), another member of the hedgehog pathway whose protein is normally repressed by the patched protein. All subtypes of BCCs have mutations in PTCH or SMOH, indicating that mutations in one or the other of these genes are essential to the development of BCCs but do not dictate the histologic subtype. Furthermore, other genetic alterations known to occur in BCCs, such as p53 or RAS gene mutations, do not correlate with variation in biologic behavior. The purpose of this study is to identify the genetic causes and molecular correlates of different histologic subtypes of basal cell carcinomas. Specific aims are to 1) determine if genetic variation in members of the hedgehog pathway downstream from PTCH and SMO contribute to variation in biological behavior of these tumors, and 2) as an indirect method of examining other genetic and epigenetic phenomena in BCCs, use microarray analysis to try to classify these tumors and identify a set of genes whose expression predicts their biological behavior.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines.
同时抑制 COX-2 和 5-LOX 活性可增强癌前和恶性人肺细胞系的生长停滞和死亡。
DOI: --
发表时间: 2007
期刊: Journal of experimental therapeutics & oncology
影响因子: --
作者: [Schroeder,ClaudiaP, Yang,Peiying, Newman,RobertA, Lotan,Reuben]
通讯作者: Lotan,Reuben
Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.
临床相关浓度的塞来昔布和 4HPR 组合可增强 NSCLC 细胞系的生长抑制和凋亡诱导。
DOI: 10.4161/cbt.4.4.1618
发表时间: 2005
期刊: Cancer biology & therapy
影响因子: 3.6
作者: [Sun,Shi-Yong, Schroeder,ClaudiaP, Yue,Ping, Lotan,Dafna, Hong,WaunK, Lotan,Reuben]
通讯作者: Lotan,Reuben
Genetic epidemiology of early-onset basal cell carcinoma
  • 批准号:
    7992021
  • 项目类别:
  • 资助金额:
    $8.28万
  • 财政年份:
    2010
  • 负责人:
    Allen Everett Bale
  • 依托单位:
Genetic epidemiology of early-onset basal cell carcinoma
  • 批准号:
    8107696
  • 项目类别:
  • 资助金额:
    $8.03万
  • 财政年份:
    2010
  • 负责人:
    Allen Everett Bale
  • 依托单位:
Program Planning and Evaluation
  • 批准号:
    7513168
  • 项目类别:
  • 资助金额:
    $3.38万
  • 财政年份:
    2007
  • 负责人:
    Allen Everett Bale
  • 依托单位:
Research Programs-Cancer Genetics
  • 批准号:
    7513238
  • 项目类别:
  • 资助金额:
    $1.6万
  • 财政年份:
    2007
  • 负责人:
    Allen Everett Bale
  • 依托单位:
海外基金